Holen Sie sich die Stockscreener-App
189.08
2.20%
4.07
Handel nachbörslich:
190.00
0.92
+0.49%
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
MassMutual Private Wealth & Trust FSB Sells 7,073 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
A Voice for Advocacy and Awareness in HER2+ Gastroesophageal AdenocarcinomaJazz Pharmaceuticals - Oncodaily
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education - Lelezard
Is Jazz Pharmaceuticals (JAZZ) one of the best cheap biotech stocks to buy now? - MSN
People with sleep disorders to get guidance on sodium, heart risk - Stock Titan
Is the options market predicting a spike in Jazz Pharmaceuticals stock? - MSN
How New Ziihera and JZP898 Data from AACR 2026 Will Impact Jazz Pharmaceuticals (JAZZ) Investors - simplywall.st
Jazz Pharmaceuticals plc (JAZZ) reports $1.2 billion Q4 revenue, beats $1.17B estimate - MSN
Groupama Asset Managment Lowers Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals’ EBITDA Set to Surge 175% in 2026: Here’s What’s Next - TIKR.com
Narcolepsy Therapeutics Market (2025) | Central Nervous System - openPR.com
Why is Jazz Pharmaceuticals plc stock going up2026 Technical Overview & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Piper Sandler Maintains Overweight Rating for JAZZ, Raises Price Target | JAZZ Stock News - GuruFocus
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $232.00 Price Target at Piper Sandler - MarketBeat
Piper Sandler raises Jazz Pharmaceuticals stock price target on growth outlook - Investing.com UK
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026 - Yahoo Finance
A Look At Jazz Pharmaceuticals (JAZZ) Valuation As New Oncology Data Heads To The 2026 AACR Meeting - Yahoo Finance
Goldentree Asset Management LP Takes $149.60 Million Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals plc Denmark Finland France Germany Netherlands Sweden United Kingdom Ireland - AD HOC NEWS
JAZZ stock rises as Q4 earnings & sales top expectations - MSN
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting - Yahoo Finance
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 - PR Newswire
Faithward Advisors LLC Increases Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Aug Swings: Can Jazz Pharmaceuticals plc ride the EV wave2026 Major Catalysts & Expert-Curated Trade Recommendations - baoquankhu1.vn
Fundamentals Check: Can Jazz Pharmaceuticals plc ride the EV waveDip Buying & High Conviction Buy Zone Picks - baoquankhu1.vn
Holocene Advisors LP Acquires 135,367 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Ameriprise Financial Inc. Cuts Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Buybacks Report: Can Jazz Pharmaceuticals plc expand its profit margins2026 PostEarnings & Growth Oriented Trade Recommendations - baoquankhu1.vn
Iron Triangle Partners LP Makes New $19.77 Million Investment in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Aristotle Capital Management LLC - MarketBeat
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead? - TradingView
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Bank of Montreal Can - MarketBeat
Jazz Pharmaceuticals (JAZZ) Price Forecast: Multi-Year Base Signals Breakout Potential - FXEmpire
Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights - Investing.com Nigeria
Capital World Investors Increases Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Crossmark Global Holdings Inc. Sells 10,433 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Revenue And Supportive Barclays Commentary - simplywall.st
Jazz Pharmaceuticals Stock at $185: Here’s Why Analysts See a New All-Time High in 2026 - TIKR.com
Jazz’s 2025 Net Loss and 2026 Outlook Might Change The Case For Investing In JAZZ - simplywall.st
Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Sells $235,443.78 in Stock - MarketBeat
Tax-withholding share disposition by Jazz Pharmaceuticals (JAZZ) director - Stock Titan
Jazz Pharmaceuticals (JAZZ) CFO reports tax-withholding share disposition - Stock Titan
Jazz Pharmaceuticals (JAZZ) EVP has 2,503 shares withheld to cover RSU taxes - Stock Titan
Jazz Pharmaceuticals (JAZZ) SVP Patricia Carr reports share sales - Stock Titan
Jazz Pharmaceuticals (JAZZ) CEO has shares withheld to cover RSU taxes - Stock Titan
Barclays reiterates Jazz Pharmaceuticals stock rating on CNS strength - Investing.com Nigeria
Patricia Carr (NASDAQ: JAZZ) files Form 144 showing recent share sales - Stock Titan
JAZZ or ACAD: Which Is the Better Value Stock Right Now? - Yahoo Finance
S&P 500 Futures Fall in Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead - Barron's
American Century Companies Inc. Sells 36,599 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Victory Capital Management Inc. - MarketBeat
Rhenman & Partners Asset Management AB Cuts Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals (JAZZ) Still Attractive After Recent Share Price Strength - Yahoo Finance
Jazz Pharmaceuticals Revenue Record Puts Focus On Zanidatamab And Valuation - simplywall.st
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):